Default Image
11, Dec 2025
MediGlo Clinic Launches “Exion,” a Needle-Free Skin Treatment in Gurugram

Dec 11:-  MediGlo Clinic, a leader in advanced skincare innovation, has announced the launch of Exion, an advanced needle-free treatment designed to safely and effectively address a wide range of skin concerns.

MediGlo

Exion provides a completely non-invasive option for individuals seeking youthful, radiant skin without the pain, discomfort, or downtime associated with traditional dermatological procedures. The treatment is particularly effective for concerns such as fine lines, uneven skin texture, pigmentation, dullness, and loss of elasticity.

Powered by cutting-edge technology, Exion gently stimulates natural collagen production, boosts skin hydration, and enhances overall skin luminosity, making it suitable for all skin types. With zero needles involved, the experience is comfortable even for clients who prefer to avoid injectables or invasive therapies while still achieving visible, long-lasting results.

Speaking about the launch, the MediGlo Clinic team shared,
“Exion reflects our ongoing commitment to delivering innovative, patient-centric skincare. We are thrilled to introduce a treatment in Gurugram that offers both efficacy and comfort, giving clients an advanced yet gentle pathway to glowing, rejuvenated skin.”

Exion is now available at MediGlo Clinic, Gurugram, offering residents a modern, needle free approach to skin rejuvenation. The launch further strengthens the clinic’s mission to provide accessible, effective, and comfort-driven skincare solutions that align with global advancements in aesthetic care.

With Exion, MediGlo continues to redefine skincare by blending innovation, safety, and sophistication—empowering clients to achieve healthy, youthful skin effortlessly.

Related Posts

Habuild Launches ‘Har Ghar Yoga’ to Help India Start the Year with Healthy Habits

Habuild, India’s first habit-building platform, has announced the launch of its flagship initiative Har Ghar Yoga, encouraging individuals to begin…

Star Bio Pharma Strengthens India’s Healthcare and Wellness Ecosystem with Trusted B2B Solutions

May 25 : As the pharmaceutical, nutraceutical, and herbal wellness industries continue to witness rapid growth, the need for dependable…

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial

Study will advance into expanded patient populations with myelodysplastic syndrome (MDS) and myelofibrosis (MF) SOUTH SAN FRANCISCO, Calif., April 15, 2026: CERo Therapeutics…